Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2024-11-19 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Form of Proxy for use at the Extraordinary General Meeting to be held on Thursday, December 12, 2024
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for use at an Extraordinary General Meeting (EGM) of PW Medtech Group Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions at the EGM, specifically regarding approval of a renewed sales framework agreement and related transactions. The content is procedural and related to voting arrangements for a shareholder meeting, not a report or announcement of financial results or management changes. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-11-19 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for PW Medtech Group Limited. It includes details about the meeting date, location, agenda items (approval of a renewed sales framework agreement and related transactions), proxy voting instructions, and board composition. There are no financial statements, earnings data, or detailed management analysis. The document is a formal announcement inviting shareholders to attend and vote at the EGM, which fits the definition of a Proxy Solicitation & Information Statement (PSI) or a meeting notice. Since it is specifically a notice for an EGM with resolutions to be voted on, it aligns best with the Proxy Solicitation & Information Statement category rather than a report or announcement of voting results. Therefore, the appropriate classification is PSI.
2024-11-19 English
RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO SALES OF MEDICAL DEVICES AND NOTICE OF EGM
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from PW Medtech Group Limited regarding the renewal of continuing connected transactions related to sales of medical devices. It includes a letter from the Board, letters from the Independent Board Committee and Independent Financial Adviser, and a notice of an Extraordinary General Meeting (EGM) to approve the transactions and annual caps. The document contains detailed information about the transaction terms, pricing policy, and meeting arrangements. It is not a financial report, earnings release, or audit report. It is a shareholder communication providing information and requesting approval for a specific transaction at an EGM. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or notice. Therefore, the appropriate classification is PSI with high confidence.
2024-11-19 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document includes confirmations of compliance with listing rules and regulatory requirements. It is a regulatory disclosure about share repurchase activity rather than a financial report or earnings release. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is POS with high confidence.
2024-11-18 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares and treasury shares, including share repurchases and on-market sales. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share changes. The content includes detailed tables of share repurchase transactions, confirmation statements about compliance with listing rules, and notes explaining the disclosure requirements. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about share repurchases and treasury share transactions. This fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback or sale of its own shares.
2024-11-15 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares and treasury shares, including share repurchases and on-market sales. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share changes. The content includes detailed tables of share repurchase transactions, confirmation statements about compliance with listing rules, and notes explaining the disclosure requirements. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about share repurchases and treasury share transactions. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement of a report publication or a certification. Therefore, the appropriate classification is POS with high confidence.
2024-11-14 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.